Similar Posts
Ivermectin Video: Its History, Usefulness and Suppression. 24 minutes
Here is another link that is working for me: https://tv.gab.com/channel/gordr/view/the-story-of-ivermectin-vs-remdesivir-603bc089f92a30bda575a1ed
Stopgap Booster #4, the truth on natural immunity, and the abysmal performance of COVID vaccines 4-6 months after inoculation
Read below: the NY Times reported that “A second booster is at best a stopgap measure.” Even the NYT admits the concept of boosters protecting you from COVID is a pipe dream. The NYT. If you still think vaccines are going to save you, get over it. And get early treatment when you get it….
In order to fake (reduce) the rate of anaphylaxis immediately after Moderna’s vaccine, CDC uses a prohibited database
https://childrenshealthdefense.org/defender/did-cdc-mislead-public-allergic-reactions-moderna-vaccine/ 01/28/21 Did CDC Deliberately Mislead Public on Allergic Reactions to Moderna Vaccine? The CDC had more accurate and up-to-date data that it could have used to calculate the rate of severe allergic reactions to Moderna’s COVID vaccine — why didn’t it By Meryl Nass, MD and John Stone On Jan. 13, California health officials issued a hold on…
More monoclonal or polyclonal antibodies recommended for treating Ebola/ Reuters
This type of approach is what I recommended in my Congressional testimony in 2001, for many potential pathogens, following the anthrax letters. What are monoclonal antibodies? The human immune system takes apart microbial pathogens and manufactures antibodies to a variety of sites on the microbe, honing its response as the infection progresses. Nearly 40 years…
CDC’s Withholding Information on its Civilian Anthrax Trial is a Travesty
Why did the most important trial to have been conducted on anthrax vaccine safety (by CDC between 2002 and 2007, with 1564 civilian subjects) only publish an interim report, and never discussed the 229 serious adverse events reported in trial participants? The trial tested serologic efficacy also. The investigators published partial data in JAMA on…
Glaxo starts testing its swine flu vaccine/ Associated Press
Excerpts from this Aug 15, 2009 story from the AP: In Europe, Glaxo is testing vaccines with an adjuvant, a chemical compound used to stretch a vaccine’s active ingredient and boost the body’s immune response. In Canada and the United States, Glaxo is testing vaccines both with and without adjuvants. Neither country has ever licensed…